CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • October 1st, 2020 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated September 30, 2020, is by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation (“Parent”) and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as rights agent (the “Rights Agent”).
